Package Leaflet: Information for the Patient
Bretaris Genuair 322micrograms powder for inhalation
aclidinium (aclidinium bromide)
Read this package leaflet carefully before you start using this medicine, because it contains important information for you.
Contents of the package leaflet:
Instructions for use
What is Bretaris Genuair
The active substance of Bretaris Genuair is aclidinium bromide, which belongs to a class of medicines called bronchodilators. Bronchodilators relax the airways and help keep the bronchioles open. Bretaris Genuair is a dry powder inhaler that uses your breath to deliver the medicine directly into the lungs. This makes it easier for patients with chronic obstructive pulmonary disease (COPD) to breathe.
What is Bretaris Genuair used for
Bretaris Genuair is indicated to help open up the airways and relieve the symptoms of COPD, a serious long-term lung disease that makes it difficult to breathe. Regular use of Bretaris Genuair can help you when you experience persistent difficulty breathing due to the disease, to help minimize the effects of the disease on your daily life, and reduce the number of exacerbations (worsening of COPD symptoms over several days).
Do not use Bretaris Genuair:
Warnings and precautions
Talk to your doctor, pharmacist, or nurse before you start using Bretaris Genuair:
Bretaris Genuair is indicated for maintenance treatment and should not be used to treat a sudden attack of difficulty breathing or wheezing. If your COPD symptoms (difficulty breathing, wheezing, or coughing) do not improve or worsen, you should consult your doctor as soon as possible.
Dry mouth, which has been observed with medicines like Bretaris Genuair, may be associated with tooth decay after prolonged use of the medicine. Therefore, remember to take care of your oral hygiene.
Stop using Bretaris Genuair and seek medical help immediately if:
Children and adolescents
Bretaris Genuair should not be used in children or adolescents under 18 years of age.
Using Bretaris Genuair with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Inform your doctor if you have used or are using similar medicines for respiratory problems, such as medicines containing tiotropium, ipratropium. In case of doubt, consult your doctor or pharmacist. The use of Bretaris Genuair with these medicines is not recommended.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine. You should not use Bretaris Genuair if you are pregnant or breastfeeding unless your doctor has recommended it.
Driving and using machines
Bretaris Genuair has a minor influence on the ability to drive and use machines. This medicine may cause headache, dizziness, or blurred vision. If you experience any of these adverse reactions, do not drive or use machines until your headache has disappeared, the feeling of dizziness has passed, and your vision has returned to normal.
Bretaris Genuair contains lactose
If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
Follow exactly the instructions for administration of this medicine given by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist.
The recommended dose is one inhalation twice a day, in the morning and in the evening.
The effects of Bretaris Genuair last 12 hours, so you should try to use the Bretaris Genuair inhaler at the same time every morning and evening. This will ensure that there is always enough medicine in your body to help you breathe more easily throughout the day and night. This will also help you remember to use it.
The recommended dose can be used in elderly patients and in patients with kidney or liver problems. No dose adjustment is necessary.
COPD is a long-term disease, so it is recommended to use Bretaris Genuair every day, twice a day, and not just when you have breathing problems or other COPD symptoms.
Method of administration
This medicine is for inhalation use only.
Refer to the Instructions for Use to learn how to use the Genuair inhaler. If you are in doubt about how to use Bretaris Genuair, consult your doctor or pharmacist.
You can use Bretaris Genuair at any time, before or after meals or drinks.
If you use more Bretaris Genuair than you should
If you think you have used more Bretaris Genuair than you should, talk to your doctor or pharmacist.
If you forget to use Bretaris Genuair
If you miss a dose of Bretaris Genuair, inhale the dose as soon as you remember. However, if it is almost time for your next dose, skip the missed dose.
Do not take a double dose to make up for a forgotten dose.
If you stop using Bretaris Genuair
This medicine is for long-term treatment. If you want to stop treatment, consult your doctor first, as your symptoms may worsen.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, Bretaris Genuair can cause side effects, although not everybody gets them.
In rare cases, allergic reactions (may affect up to 1 in 1,000 patients) can occur. Stop using the medicine and contact your doctor immediately if you experience swelling of the face, throat, lips, or tongue (with or without difficulty breathing or swallowing), dizziness or fainting, rapid heartbeat, or severe swelling with itching of the skin (hives), as these may be symptoms of an allergic reaction.
The following side effects may occur when using Bretaris Genuair:
Common:may affect up to 1 in 10 patients
Uncommon:may affect up to 1 in 100 patients
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this package leaflet. You can also report side effects directly through the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the inhaler label and the carton after “EXP”. The expiry date is the last day of the month shown.
Keep the Genuair inhaler in the bag until you start treatment.
Use within 90 days of opening the bag.
Do not use Bretaris Genuair if you notice the packaging is damaged or shows signs of tampering.
Once you have used the last dose, the inhaler should be discarded. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Bretaris Genuair Composition
Appearance of the Product and Package Contents
Bretaris Genuair is a white or almost white powder.
The Genuair inhaler device is white with an integrated dose indicator and a green dosing button. The mouthpiece is covered by a removable green protective cap. It is provided in a plastic bag.
Available package sizes:
Package containing 1 inhaler with 30 doses.
Package containing 1 inhaler with 60 doses.
Package containing 3 inhalers with 60 doses each.
Only some package sizes may be marketed.
Marketing Authorization Holder
Covis Pharma Europe B.V.
Gustav Mahlerplein 2
1082MA Amsterdam
Netherlands
Manufacturer
Industrias Farmacéuticas Almirall, S.A.
Ctra. de Martorell 41-61
08740 Sant Andreu de la Barca, Barcelona
Spain
You can request more information about this medication by contacting the local representative of the marketing authorization holder:
Belgium/Belgique/Belgien Covis Pharma Europe B.V. Tel: 80013067 | Lithuania UAB "BERLIN-CHEMIE MENARINI BALTIC" Tel: +370 52 691 947 |
Luxembourg/Luxemburg Covis Pharma Europe B.V. Tel: 80024119 | |
Czech Republic Berlin-Chemie/A.Menarini Ceska republika s.r.o. Tel: +420 267 199 333 | Hungary Berlin-Chemie/A. Menarini Kft. Tel.: +36 23501301 |
Denmark Covis Pharma Europe B.V. Tlf: 80711260 | Malta Covis Pharma Europe B.V. Tel: 80065149 |
Germany Berlin-Chemie AG Tel: +49 (0) 30 67070 Covis Pharma Europe B.V. Tel: +49 (0) 3031196978 | Netherlands Covis Pharma Europe B.V. Tel: 08000270008 |
Estonia OÜ Berlin-Chemie Menarini Eesti Tel: +372 667 5001 | Norway Covis Pharma Europe B.V. Tlf: 80031492 |
Greece MENARINI HELLAS AE Τηλ: +30 210 8316111-13 | Austria
Tel: +43 1 879 95 85-0 |
Spain Laboratorios Menarini S.A. Tel: +34-93 462 88 00 | Poland Covis Pharma Europe B.V. Tel.: 0800919353 |
France MENARINI France Tél: +33 (0)1 45 60 77 20 | Portugal
Tel: +351 210 935 500 |
Croatia Berlin-Chemie Menarini Hrvatska d.o.o. Tel: + 385 1 4821 361 | Romania Berlin-Chemie A.Menarini S.R.L. Tel: +40 21 232 34 32 |
Ireland Covis Pharma Europe B.V. Tel: 1800937485 | Slovenia Berlin-Chemie/ A. Menarini Distribution Ljubljana d.o.o. Tel: +386 01 300 2160 |
Iceland Covis Pharma Europe B.V. Sími: 8007279 | Slovakia Berlin-Chemie /A. Menarini Distribution Slovakia s.r.o. Tel: +421 2 544 30 730 |
Italy Laboratori Guidotti S.p.A.Tel: +39- 050 971011 | Finland Covis Pharma Europe B.V. Puh/Tel: 0800413687 |
Cyprus Covis Pharma Europe B.V. Τηλ: 80091079 | Sweden Covis Pharma Europe B.V. Tel: 0200898678 |
Latvia SIA Berlin-Chemie/Menarini Baltic Tel: +371 67103210 | United Kingdom (Northern Ireland) Covis Pharma Europe B.V. Tel: 08004334029 |
Date of Last Revision of this Leaflet:
Detailed information on this medication is available on the European Medicines Agency website: http://www.ema.europa.eu.
Instructions for Use
This section contains information on how to use your Genuair inhaler. It is important that you read this information, as Genuair may work differently from inhalers you have used before. If you have any questions about how to use your inhaler, ask your doctor, pharmacist, or nurse for help.
The instructions for use are divided into the following sections:
The disposal of unused medication and all materials that have come into contact with it will be carried out in accordance with local regulations.
How to Start:
Read these instructions for use before starting to use the medication
Familiarize yourself with the parts of your Genuair inhaler
Before Use:
STEP 1: Prepare your dose
When you press the orange button down and all the way, the control window will change from red to green.
Make sure the orange button is up. Do not tilt it. |
Make sure to release the button so that the inhaler can function correctly. |
Stop and Check:
Your medication is ready to be inhaled.
Go to "STEP 2: Inhale your medication".
What to do if the control window remains red after pressing the button (Figure H). The dose is not prepared. Go back to "STEP 1 Prepare your dose" and repeat steps 1.1 to 1.6. |
STEP 2: Inhale your medication
Read the complete steps from 2.1 to 2.7 before using. Do not tilt it. |
2.1 Keep the inhaler away from your mouth and exhale completely.Never exhale into the inhaler (Figure I).
2.2 Keep your head upright, place the mouthpiece between your lips, and close them tightly around the mouthpiece (Figure J).
Do not keep the orange button pressed while inhaling. |
2.3 Take a strong and deep breaththrough your mouth. Continue breathing in for as long as possible.
A "click" will let you know that you have inhaled correctly. Continue breathing in for as long as possible after hearing the "click". Some patients may not hear the "click". Use the control window to make sure you have inhaled correctly. |
2.4 Remove the inhaler from your mouth.
2.5 Hold your breath for as long as possible.
2.6 Breathe out slowly away from the inhaler.
Some patients may experience a gritty sensation in the mouth or a slightly sweet or bitter taste. Do not inhale an extra dose if you do not notice any taste or feel nothing after inhaling. |
Stop and Check:
2.7 Make sure the control window is now red (Figure K). This means you have inhaled your medication correctly.
What to do if the control window remains green after inhaling (Figure L). This means you have not inhaled your medication correctly. Go back to "STEP 2 Inhale your medication" and repeat steps 2.1 to 2.7. If the control window still does not change to red, you may have forgotten to release the orange button before inhaling, or you may not have inhaled strongly enough. If this happens, try again. Make sure you have released the orange button and that you have exhaled completely. Then take a strong and deep breath through the mouthpiece. Please contact your doctor if the control window remains green after several attempts. |
Put the protective cap back on the mouthpiece after each use (Figure M), to prevent contamination of the inhaler with dust or other materials. You must discard your inhaler if you lose the cap.
Additional Information:
What should you do if you accidentally load a dose?
Keep your inhaler with the protective cap in place until it is time to inhale your medication, then remove the cap and start at step 1.6.
How does the dose indicator work?
When should you get a new inhaler?
You should get a new inhaler:
How do you know if your inhaler is empty?
When the orange button does not return to its upper position and remains stuck in a middle position, it has reached the last dose (Figure O). Even when the orange button is stuck, you can still inhale the last dose. After that, the inhaler cannot be used again and you should start using a new inhaler.
How should you clean the inhaler?
NEVER use water to clean the inhaler as it could damage your medication.
If you want to clean your inhaler, simply wipe the outside of the mouthpiece with a dry cloth or paper towel.
The average price of BRETARIS GENUAIR (Inhalation Capsule) in October, 2025 is around 47.61 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.